Insider: Sachdev Amit EVP Chief Patient & Ext Af Off - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 55,325 | 0 | 55,325 |
| Value | $21,126,957.75 | $0.00 | $21,126,957.75 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/15/2024 | DDS | 32 | Direct | COM | $430.93 | $13,789.76 | 55,325 |
| 02/26/2024 | DDS | 3,004 | Direct | COM | $425.70 | $1,278,802.80 | 55,325 |
| 02/21/2024 | DDS | 3,191 | Direct | COM | $421.77 | $1,345,868.07 | 60,798 |
| 02/20/2024 | DDS | 4,254 | Direct | COM | $420.79 | $1,790,040.66 | 63,989 |
| 02/12/2024 | DDS | 3,222 | Direct | COM | $420.24 | $1,354,013.28 | 74,364 |
| 11/15/2023 | DDS | 35 | Direct | COM | $369.92 | $12,947.20 | 58,814 |
| 08/10/2023 | DDS | 10,031 | Direct | COM | $350.00 | $3,510,850.00 | 58,814 |
| 11/15/2021 | DDS | 30 | Direct | COM | $187.48 | $5,624.40 | 31,928 |
| 11/15/2021 | DDS | 21 | Direct | COM | $186.78 | $3,922.38 | 31,958 |
| 05/17/2021 | DDS | 8 | Direct | COM | $215.59 | $1,724.72 | 40,170 |
| 05/17/2021 | DDS | 32 | Direct | COM | $216.40 | $6,924.80 | 40,138 |
| 05/17/2021 | DDS | 5 | Direct | COM | $217.27 | $1,086.35 | 40,133 |
| 02/25/2021 | DDS | 922 | Direct | COM | $211.56 | $195,058.32 | 42,797 |
| 02/25/2021 | DDS | 1,460 | Direct | COM | $213.30 | $311,418.00 | 41,337 |
| 02/25/2021 | DDS | 336 | Direct | COM | $215.56 | $72,428.16 | 40,333 |
| 02/25/2021 | DDS | 668 | Direct | COM | $214.19 | $143,078.92 | 40,669 |
| 02/25/2021 | DDS | 200 | Direct | COM | $216.62 | $43,324.00 | 40,133 |
| 02/11/2021 | DDS | 3,860 | Direct | COM | $210.43 | $812,259.80 | 64,142 |
| 02/11/2021 | DDS | 100 | Direct | COM | $211.98 | $21,198.00 | 63,542 |
| 02/11/2021 | DDS | 500 | Direct | COM | $211.22 | $105,610.00 | 63,642 |
| 08/03/2020 | DDS | 500 | Direct | COM | $276.96 | $138,480.00 | 36,544 |
| 08/03/2020 | DDS | 751 | Direct | COM | $279.18 | $209,664.18 | 35,103 |
| 08/03/2020 | DDS | 690 | Direct | COM | $278.25 | $191,992.50 | 35,854 |
| 05/15/2020 | DDS | 10 | Direct | COM | $280.34 | $2,803.40 | 35,146 |
| 05/15/2020 | DDS | 3 | Direct | COM | $276.21 | $828.63 | 35,157 |
| 1 2 3 4 5 6 7 8 9 10 Next Last You are at page 1 of 10 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research